In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...

-The Times of India Fears that policy paralysis will continue after the Congress party's poor show in the Uttar Pradesh assembly elections unnerved investors, and the sensex lost 190 points on Tuesday to end the day at 17173, its worst close in six weeks. The trepidation in the markets also affected shares of a few Anil Ambani-promoted Reliance Group companies, even though they were actually expected to gain because of the...

The amount of rural reportage in the Indian media remains far too low, with even important stories such as those on farmer suicides tending to be ignored. One of the outspoken critics of this trend has been P Sainath, rural-affairs editor of The Hindu  and 2007 winner of the Ramon Magsaysay Award for Journalism, Literature and Creative Communication Arts. He was also the journalist who originally broke the story on...

Soon, the National Food Security Act  will become law. The ruling United Progressive Alliance flagship social security programme of providing every Below the Poverty Line (BPL) family with 25 kg of rice or wheat at Rs 3 per kg per month is a welcome step to alleviate some of the human trauma that haunts the poor in our country. The government also hopes that the Act will secure freedom from...